150 related articles for article (PubMed ID: 36837490)
1. Associations between Body Mass Index and Prostate Cancer: The Impact on Progression-Free Survival.
Popovici D; Stanisav C; Pricop M; Dragomir R; Saftescu S; Ciurescu D
Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837490
[No Abstract] [Full Text] [Related]
2. Body mass index affects the diagnosis and progression of prostate cancer in Hispanics.
Negrón R; Vásquez A; Nieves M; Guerrios L; Irizarry-Ramírez M
Ethn Dis; 2010; 20(1 Suppl 1):S1-168-72. PubMed ID: 20521409
[TBL] [Abstract][Full Text] [Related]
3. The role of the digital rectal examination as diagnostic test for prostate cancer detection in obese patients.
Dell'Atti L
J BUON; 2015; 20(6):1601-5. PubMed ID: 26854458
[TBL] [Abstract][Full Text] [Related]
4. Obesity is associated with castration-resistant disease and metastasis in men treated with androgen deprivation therapy after radical prostatectomy: results from the SEARCH database.
Keto CJ; Aronson WJ; Terris MK; Presti JC; Kane CJ; Amling CL; Freedland SJ
BJU Int; 2012 Aug; 110(4):492-8. PubMed ID: 22094083
[TBL] [Abstract][Full Text] [Related]
5. [Relationship between serum prostate-specific antigen levels and body mass index in Beijing men over 50 years of age].
Wang Y; Zhou Z; Tian Y; Shao Q; Chen S; Hong BF; Zhang XH; Ren XH; Sun WX; Wang ZW; Na YQ
Zhonghua Yi Xue Za Zhi; 2009 Jun; 89(24):1681-3. PubMed ID: 19957525
[TBL] [Abstract][Full Text] [Related]
6. Correlation of High Body Mass Index With More Advanced Localized Prostate Cancer at Radical Prostatectomy Is Not Reflected in PSA Level and PSA Density but Is Seen in PSA Mass.
Kryvenko ON; Epstein JI; Meier FA; Gupta NS; Menon M; Diaz M
Am J Clin Pathol; 2015 Aug; 144(2):271-7. PubMed ID: 26185312
[TBL] [Abstract][Full Text] [Related]
7. Low body mass index is associated with adverse oncological outcomes following radical prostatectomy in Korean prostate cancer patients.
Koo KC; Yoon YE; Rha KH; Chung BH; Yang SC; Hong SJ
Int Urol Nephrol; 2014 Oct; 46(10):1935-40. PubMed ID: 24817520
[TBL] [Abstract][Full Text] [Related]
8. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
9. Influence of body mass index on biochemical outcome after permanent prostate brachytherapy.
Merrick GS; Butler WM; Wallner KE; Galbreath RW; Allen Z; Lief JH; Adamovich E
Urology; 2005 Jan; 65(1):95-100. PubMed ID: 15667872
[TBL] [Abstract][Full Text] [Related]
10. Body mass index, prostate-specific antigen, and digital rectal examination findings among participants in a prostate cancer screening clinic.
Price MM; Hamilton RJ; Robertson CN; Butts MC; Freedland SJ
Urology; 2008 May; 71(5):787-91. PubMed ID: 18267334
[TBL] [Abstract][Full Text] [Related]
11. Obesity inversely correlates with prostate-specific antigen levels in a population with normal screening results of prostate cancer in northwestern China.
Zhang J; Ma M; Nan X; Sheng B
Braz J Med Biol Res; 2016 Jul; 49(8):. PubMed ID: 27409334
[TBL] [Abstract][Full Text] [Related]
12. Is the body mass index a predictor of adverse outcome in prostate cancer after radical prostatectomy in a mid-European study population?
Pfitzenmaier J; Pritsch M; Haferkamp A; Jakobi H; Fritsch F; Gilfrich C; Djakovic N; Buse S; Pahernik S; Hohenfellner M
BJU Int; 2009 Apr; 103(7):877-82. PubMed ID: 19007372
[TBL] [Abstract][Full Text] [Related]
13. Impact of body mass index on clinicopathological outcome and biochemical recurrence after radical prostatectomy.
Narita S; Mitsuzuka K; Yoneyama T; Tsuchiya N; Koie T; Kakoi N; Kawamura S; Kaiho Y; Ohyama C; Tochigi T; Yamaguchi T; Habuchi T; Arai Y
Prostate Cancer Prostatic Dis; 2013 Sep; 16(3):271-6. PubMed ID: 23752230
[TBL] [Abstract][Full Text] [Related]
14. Effect of body mass index on serum prostate-specific antigen levels among patients presenting with lower urinary tract symptoms.
Chiu PK; Wong AY; Hou SM; Yip SK; Ng CF
Asian Pac J Cancer Prev; 2011; 12(8):1937-40. PubMed ID: 22292628
[TBL] [Abstract][Full Text] [Related]
15. Impact of obesity on the utility of preoperative prostate-specific antigen velocity to predict for relapse after prostatectomy: a report from the SEARCH database.
King CR; Freedland SJ; Terris MK; Kane CJ; Amling CL; Aronson WJ; Presti JC
Urology; 2007 May; 69(5):921-6. PubMed ID: 17482935
[TBL] [Abstract][Full Text] [Related]
16. Body mass index and prostate cancer severity: do obese men harbor more aggressive disease on prostate biopsy?
Chamie K; Oberfoell S; Kwan L; Labo J; Wei JT; Litwin MS
Urology; 2013 May; 81(5):949-55. PubMed ID: 23477756
[TBL] [Abstract][Full Text] [Related]
17. Inverse correlation between body mass index and clinical outcomes in men with advanced castration-recurrent prostate cancer.
Halabi S; Ou SS; Vogelzang NJ; Small EJ
Cancer; 2007 Oct; 110(7):1478-84. PubMed ID: 17665494
[TBL] [Abstract][Full Text] [Related]
18. Higher body mass index increases the risk for biopsy-mediated detection of prostate cancer in Chinese men.
Hu MB; Bai PD; Wu YS; Zhang LM; Xu H; Na R; Jiang HW; Ding Q
PLoS One; 2015; 10(4):e0124668. PubMed ID: 25861033
[TBL] [Abstract][Full Text] [Related]
19. The effect of obesity and lower serum prostate-specific antigen levels on prostate-cancer screening results in American men.
Culp S; Porter M
BJU Int; 2009 Nov; 104(10):1457-61. PubMed ID: 19522868
[TBL] [Abstract][Full Text] [Related]
20. Association between obesity and frequency of high-grade prostate cancer on biopsy in men: A single-center retrospective study.
Baio R; Napodano G; Caruana C; Molisso G; Di Mauro U; Intilla O; Pane U; D'Angelo C; Francavilla AB; Guarnaccia C; Pentimalli F; Sanseverino R
Mol Clin Oncol; 2022 Aug; 17(2):127. PubMed ID: 35832470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
